Scientific study shows that GARDskin™ is the most accurate test for skin sensitization of chemical substances
Lund, 31 July 2018 – SenzaGen (Nasdaq First North: SENZA) announces today that a new scientific study shows that GARDskin™ can provide producers and contract laboratories with a single test for evaluating substances, with an increased accuracy as compared with the recommended combination of current market leading methods. The reason for this recommendation by regulatory authorities is the relatively low accuracy of the currently available individual methods. The positive results from the published study shows that GARDskin™ could be established as the first animal-free standalone test and